Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Reply

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Abatacept after Rituximab in rheumatoid arthritis. a Pan-European Collaboration of RA Registries.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  3. M-ficolin levels reflect disease activity and predict remission in early rheumatoid arthritis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Headache in systemic lupus erythematosus: results from a prospective, international inception cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
To compare tumor necrosis factor alpha inhibitors directly regarding the rates of treatment response, remission, and the drug survival rate in patients with rheumatoid arthritis (RA), and to identify clinical prognostic factors for response.
Original languageEnglish
JournalArthritis & Rheumatism
Volume62
Issue number1
Pages (from-to)22-32
Number of pages11
ISSN0004-3591
DOIs
Publication statusPublished - 1 Jan 2010

ID: 32219357